51 Biggest Movers From Yesterday
Gainers
- Advent Technologies Holdings, Inc. NASDAQ:ADN shares climbed 79.7% to close at
$3.63 on Wednesday. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales and development agreement. - Tufin Software Technologies Ltd. NYSE:TUFN surged 43.1% to close at
$12.92 after the company announced it will be acquired by Turn/River Capital for$13 per share in cash. - Moxian BVI Inc NASDAQ:MOXC gained 39.8% to close at
$2.32 on above-average volume. - Mobiquity Technologies, Inc. NASDAQ:MOBQ surged 29.6% to close at
$2.10 after the company announced it has been selected by A-Nation as its data and programmatic advertising provider. - Newegg Commerce, Inc. NASDAQ:NEGG gained 27.2% to close at
$8.66 on above-average volume. - Alset EHome International Inc. NASDAQ:AEI jumped 24.3% to close at
$0.6847 . Alset EHome International recently reported FY2021 results with a 22% revenue growth. - Missfresh Limited NASDAQ:MF gained 23.4% to close at
$1.58 . - Team, Inc. NYSE:TISI climbed 22.4% to close at
$2.73 . Team recently regained compliance with NYSE listing standards. - Nuvectis Pharma, Inc. NASDAQ:NVCT climbed 18.9% to close at
$10.25 . - Enlivex Therapeutics Ltd. NASDAQ:ENLV rose 17.5% to settle at
$8.64 . - Fang Holdings Limited NYSE:SFUN gained 17.1% to settle at
$4.3927 . Fang, in February, appointed Mr.Peng Cui as CFO. - Icosavax, Inc. NASDAQ:ICVX jumped 16.3% to close at
$7.57 . Icosavax recently reported Q4 results. - Concord Medical Services Holdings Limited NYSE:CCM rose 14.9% to close at
$1.8962 . - Venator Materials PLC NYSE:VNTR gained 14.6% to close at
$1.96 after the company won its$75 million lawsuit against Tronox. - Sunshine Biopharma, Inc. NASDAQ:SBFM climbed 12.1% to close at
$6.29 . Sunshine Biopharma announced that two of its newly designed mRNA molecules are effective at destroying cancer cells grown in culture. - Fresh Vine Wine, Inc. NYSE:VINE gained 12.1% to close at
$4.16 . Fresh Vine Wine namedEllen Scipta as CFO. - Sunshine Biopharma, Inc. NASDAQ:SBFM shares rose 12.1% to close at
$6.29 . Sunshine Biopharma shares jumped 148% on Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture. - Smart Sand, Inc. NASDAQ:SND rose 10.1% to close at
$4.03 . - Guardion Health Sciences, Inc. NASDAQ:GHSI rose 9.4% to close at
$0.2316 . Guardion Health Sciences recently reported FY21 loss of$1.04 per share. - Gogo Inc. NASDAQ:GOGO shares rose 7.6% to close at
$20.65 . Gogo recently namedSergio Aguirre as President and COO.
Don't forget to check out our premarket coverage here .
Losers
- Nutex Health Inc. NASDAQ:NUTX fell 32.8% to close at
$17.90 . - Guardforce AI Co., Limited NASDAQ:GFAI dipped 32.5% to close at
$1.14 as the company reported pricing of$10.0 million registered direct offering. - Velo3D, Inc. NYSE:VLD fell 26.5% to close at
$6.33 . - GWG Holdings, Inc. NASDAQ:GWGH dipped 25.1% to close at
$2.62 . - Dakota Gold Corp. NYSE:DC fell 21.6% to close at
$5.41 after the company was uplifted to NYSE American. - Forge Global Holdings, Inc. NYSE:FRGE dipped 21.4% to close at
$20.60 on below-average volume. - Integrated Media Technology Limited NASDAQ:IMTE fell 21.4% to close at
$20.52 . Integrated Media Technology reported distribution agreement on halal products for European Markets. - Anghami Inc. NASDAQ:ANGH dropped 20.4% to close at
$10.67 after jumping around 48% on Tuesday. - Sensus Healthcare, Inc. NASDAQ:SRTS fell 20.3% to close at
$8.78 . - Swvl Holdings Corp. NASDAQ:SWVL dropped 20.1% to close at
$6.90 . - Senmiao Technology Limited NASDAQ:AIHS shares fell 19.1% to settle at
$1.74 . Senmiao Technology reported a 1-for-10 reverse stock split, effectiveApr. 6, 2022 . - Hyzon Motors Inc. NASDAQ:HYZN fell 17.4% to close at
$5.13 after Canaccord Genuity downgraded the stock from Buy to Hold and lowered its price target from$12 to$6 . - Codex DNA, Inc. NASDAQ:DNAY dropped 16.9% to close at
$5.36 . - Celsion Corporation NASDAQ:CLSN fell 16.7% to close at
$5.18 after the company announced a$7 million registered direct offering priced at-the-market under Nasdaq rules. - Greenidge Generation Holdings Inc. NASDAQ:GREE dropped 16.7% to close at
$8.95 . - Rhythm Pharmaceuticals, Inc. NASDAQ:RYTM fell 16.3% to close at
$9.80 . Rhythm Pharmaceuticals will modify its Phase 3 EMANATE and ongoing Phase 2 DAYBREAK trials of setmelanotide in rare genetic diseases of obesity. - VEON Ltd. NASDAQ:VEON fell 15.8% to settle at
$0.5806 . - FreightCar America, Inc. NASDAQ:RAIL fell 14.7% to settle at
$5.58 . FreightCar America recently reported better-than-expected Q4 EPS and sales results. - Beam Global NASDAQ:BEEM dipped 14.2% to close at
$21.78 . - Nextdoor Holdings, Inc. NASDAQ:KIND fell 13.7% to close at
$5.55 . - GBS Inc. NASDAQ:GBS fell 12.4% to close at
$1.06 . - Homology Medicines, Inc. NASDAQ:FIXX dropped 11.8% to close at
$2.54 . Canaccord Genuity maintained Homology Medicines with a Buy and lowered the price target from$19 to$7 . - Sphere 3D Corp. NYSE:ANY fell 11.5% to close at
$2.24 . - Reviva Pharmaceuticals Holdings, Inc. NASDAQ:RVPH fell 11.1% to close at
$2.16 . - Cano Health, Inc. NYSE:CANO dipped 11.1% to close at
$5.59 after Piper Sandler downgraded the stock from Neutral to Underweight and lowered its price target from$8.50 to$5 . - Avis Budget Group, Inc. NASDAQ:CAR fell 10.9% to settle at
$246.44 after B of A Securities downgraded the stock from Neutral to Underperform and lowered its price target from$250 to$240 . - TD Holdings, Inc. NASDAQ:GLG fell 10.9% to settle at
$0.2820 . GLG Life Tech recently reported Q4 results. - Owlet, Inc. NYSE:OWLT fell 9.3% to close at
$4.22 . - Tantech Holdings Ltd NASDAQ:TANH fell 8.6% to close at
$0.6081 after surging around 31% on Tuesday. Tantech recently said its subsidiary, Shangchi Automobile Co Ltd, won an additional ten vehicle orders. - Aterian, Inc. NASDAQ:ATER shares fell 6.6% to close at
$3.41 . Aterian recently said thatCynthia Williams has joined the Company's Board of Directors. - Inventiva S.A. NASDAQ:IVA fell 6.3% to close at
$11.25 . The FDA completed a safety review of Inventiva's IND application and signed off Phase 2 combination trial with its lead drug candidate, lanifibranor.